The RIQAS Maternal Screening EQA programme is designed to monitor the performance of screening tests used during the first and second trimester of pregnancy to assess the risk of Down’s syndrome, Spina Bifida and Trisomy 18.
Accredited to ISO/IEC 17043
Lyophilised for enhanced stability
100% human serum
Monthly reporting
Submit results and view reports online via RIQAS.Net
Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
Randox Laboratories are providing the tools required to combat and detect COVID-19. We have solutions available for laboratory testing and consumer/company testing.
See the tools that Randox have to help diagnose and combat the virus.
Use the buttons below to direct you to the required pages.